Researchers have developed CMGL, a novel two-stage framework for cancer subtype classification that integrates multi-omics data. This method addresses challenges posed by varying data quality and noise across different patient samples and cancer types. CMGL estimates sample-specific modality reliability using evidential deep learning, which then guides the fusion of omics data and the construction of patient similarity graphs, leading to improved classification accuracy. AI
IMPACT Introduces a new method for improving cancer subtype classification by leveraging multi-omics data and evidential deep learning.
RANK_REASON This is a research paper detailing a new method for cancer subtype classification using multi-omics data.
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →
